AEON Biopharma, Inc. (AEON)
0.1589
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:06
AEON Biopharma Market Cap : 4.180M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 4.159M |
| November 04, 2026 | 5.488M |
| November 03, 2026 | 5.582M |
| November 02, 2026 | 7.182M |
| October 30, 2026 | 7.208M |
| October 29, 2026 | 7.734M |
| October 28, 2026 | 6.945M |
| October 27, 2026 | 6.532M |
| October 26, 2026 | 6.314M |
| October 23, 2026 | 6.311M |
| October 22, 2026 | 6.148M |
| October 21, 2026 | 6.319M |
| October 20, 2026 | 6.090M |
| October 19, 2026 | 6.077M |
| October 16, 2026 | 6.103M |
| October 15, 2026 | 6.393M |
| October 14, 2026 | 6.022M |
| October 13, 2026 | 6.043M |
| October 12, 2026 | 6.461M |
| October 09, 2026 | 7.261M |
| October 08, 2026 | 8.155M |
| October 07, 2026 | 8.188M |
| October 06, 2026 | 7.621M |
| October 05, 2026 | 7.103M |
| October 02, 2026 | 7.340M |
| Date | Value |
|---|---|
| October 01, 2026 | 7.629M |
| September 30, 2026 | 7.892M |
| September 29, 2026 | 6.814M |
| September 28, 2026 | 6.882M |
| September 25, 2026 | 6.935M |
| September 24, 2026 | 6.845M |
| September 23, 2026 | 6.942M |
| September 22, 2026 | 6.892M |
| September 21, 2026 | 6.682M |
| September 18, 2026 | 6.380M |
| September 17, 2026 | 6.480M |
| September 16, 2026 | 6.761M |
| September 15, 2026 | 6.987M |
| September 14, 2026 | 7.529M |
| September 11, 2026 | 8.600M |
| September 10, 2026 | 7.629M |
| September 09, 2026 | 6.077M |
| September 08, 2026 | 6.182M |
| September 04, 2026 | 6.335M |
| September 03, 2026 | 6.700M |
| September 02, 2026 | 7.129M |
| September 01, 2026 | 7.277M |
| August 31, 2026 | 7.784M |
| August 28, 2026 | 8.266M |
| August 27, 2026 | 7.732M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.601B |
| Alnylam Pharmaceuticals, Inc. | 21.09B |
| Anika Therapeutics, Inc. | 224.83M |
| Savara, Inc. | 934.57M |
| Vericel Corp. | 2.614B |
Market Cap Related Metrics
| Price | 0.1589 |
| Earnings Yield | -2.37K% |